Carlos Garcia Fernandez

Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device.

Idoven is a health technology company advancing early detection and precision medicine for cardiovascular diseases. The Idoven AI-powered platform delivers substantial improvements to the speed, consistency and accuracy of electrocardiogram (ECG) interpretation. Its powerful, proprietary AI algorithms, which work with existing ECG devices, are also being applied to develop disease biomarkers towards patient identification, risk stratification and prognosis, as well as drug cardiac safety monitoring. Idoven partners with leading medical device and pharmaceutical companies on AI-driven innovations to develop a new standard of cardiovascular care. Through exclusive partnerships and research collaborations, Idoven has developed one of the world’s largest ECG databases and a deep learning system applied to cardiology. The Idoven software is designed to be integrated seamlessly into existing clinical and research workflows, to support clinician decision making and disease management. Idoven has been awarded with numerous distinctions for its AI technology in Europe and the US, including the prestigious European Innovation Council (EIC) Accelerator and Horizon 2020 (H2020) awards and the Healthy Longevity Catalyst Award from the US National Academy of Medicine. The company is backed by top tier investors including Insight Partners, Northzone and Wayra (Telefónica), the Accel Starters programme, leading business angels and EIT Health. Idoven is based in Madrid and was founded in 2018, following almost a decade of ground-breaking research. We are building the future of cardiovascular care, and we need the best minds from around the world to help us. Interested in joining our team? Head to our careers page and apply at www.idoven.ai/jobs

Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device.

Idoven is a health technology company advancing early detection and precision medicine for cardiovascular diseases. The Idoven AI-powered platform delivers substantial improvements to the speed, consistency and accuracy of electrocardiogram (ECG) interpretation. Its powerful, proprietary AI algorithms, which work with existing ECG devices, are also being applied to develop disease biomarkers towards patient identification, risk stratification and prognosis, as well as drug cardiac safety monitoring. Idoven partners with leading medical device and pharmaceutical companies on AI-driven innovations to develop a new standard of cardiovascular care. Through exclusive partnerships and research collaborations, Idoven has developed one of the world’s largest ECG databases and a deep learning system applied to cardiology. The Idoven software is designed to be integrated seamlessly into existing clinical and research workflows, to support clinician decision making and disease management. Idoven has been awarded with numerous distinctions for its AI technology in Europe and the US, including the prestigious European Innovation Council (EIC) Accelerator and Horizon 2020 (H2020) awards and the Healthy Longevity Catalyst Award from the US National Academy of Medicine. The company is backed by top tier investors including Insight Partners, Northzone and Wayra (Telefónica), the Accel Starters programme, leading business angels and EIT Health. Idoven is based in Madrid and was founded in 2018, following almost a decade of ground-breaking research. We are building the future of cardiovascular care, and we need the best minds from around the world to help us. Interested in joining our team? Head to our careers page and apply at www.idoven.ai/jobs

Ayudamos a disruptores tecnológicos con equipos e ideas excepcionales que imaginan grandes compañías orientadas a la transformación digital de empresas y servicios porque creemos que es posible cambiar el mundo transformando los negocios.

Somos una consultoría de Big Data que nace por la necesidad de dar solución a los diferentes escenarios de negocio relacionados con Big Data y Analytics. Entendemos el contexto de Big Data como clave en la estrategia de las empresas y un escalón imprescindible para preparar el futuro, ser competitivo, eficiente y seguir el proceso de transformación digital del negocio. El que no aprenda de su historia (datos) está abocado a desaparecer. Nacemos con la idea de ayudar y acompañar a nuestros clientes en el proceso de definir la estrategia de datos, implementarla y conseguir resultados. Cada estrategia es diferente y depende el sector, la empresa, los objetivos de negocio, productos, canales, nivel tecnológico y madurez de los procesos. En Strategy Big Data entendemos que solo se puede definir la estrategia basándose en el valor de Big Data Ofrecemos además servicios de Outsourcing proporcionando a nuestros clientes, profesionales de experiencia contrastada que desarrollan nuestros servicios en las oficinas de nuestros clientes.

Nuestra razón de ser como universidad moderna es acompañar a los estudiantes en su crecimiento personal y profesional durante su vida académica. Formamos líderes competentes, éticos y comprometidos con la Humanidad. Más de 70.000 antiguos alumnos de todo el mundo y 80 años de historia. Amplia oferta académica en las modalidades presencial, semipresencial y online. Estamos en Salamanca y en Madrid